▶ 調査レポート

世界の骨移植・代替物市場2021年ー2028年:製品別(同種移植片、合成骨移植片、その他)、材料別、エンドユーザー別

• 英文タイトル:Bone Grafts and Substitutes Market (Product: Allograft, Synthetic Bone Graft, and Others; Material: Ceramic-based, Polymer-based, Growth Factor-based, Cell-based, and Others; and End-user: Hospitals, Orthopedic Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Transparency Market Researchが調査・発行した産業分析レポートです。世界の骨移植・代替物市場2021年ー2028年:製品別(同種移植片、合成骨移植片、その他)、材料別、エンドユーザー別 / Bone Grafts and Substitutes Market (Product: Allograft, Synthetic Bone Graft, and Others; Material: Ceramic-based, Polymer-based, Growth Factor-based, Cell-based, and Others; and End-user: Hospitals, Orthopedic Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028 / MRC2205A078資料のイメージです。• レポートコード:MRC2205A078
• 出版社/出版日:Transparency Market Research / 2022年4月30日
• レポート形態:英文、PDF、185ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥764,940 (USD5,795)▷ お問い合わせ
  Multi User¥1,160,940 (USD8,795)▷ お問い合わせ
  Corporate License¥1,556,940 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本調査資料では、世界の骨移植・代替物市場について調査し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場インサイト、製品種類別(同種移植片、合成骨移植片、異種移植片)分析、材料別分析、エンドユーザー別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などの項目を掲載しています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界の骨移植・代替物市場規模:製品種類別(同種移植片、合成骨移植片、異種移植片)
・世界の骨移植・代替物市場規模:材料別
・世界の骨移植・代替物市場規模:エンドユーザー別
・世界の骨移植・代替物市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況

Bone Grafts and Substitutes Market – Scope of Report
TMR’s report on the global bone grafts and substitutes market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global bone grafts and substitutes market for the period 2017–2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global bone grafts and substitutes market from 2021 to 2028.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the bone grafts and substitutes market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global bone grafts and substitutes market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global bone grafts and substitutes market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global bone grafts and substitutes market.

The report delves into the competitive landscape of the global bone grafts and substitutes market. Key players operating in the global bone grafts and substitutes market have been identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global bone grafts and substitutes market profiled in this report.

Key Questions Answered in Bone Grafts and Substitutes Market Report
What will be the revenue generated by the bone grafts and substitutes market across all regions during the forecast period?
What are key trends in the global bone grafts and substitutes market?
What are major drivers, restraints, and opportunities in the global market?
Which region is set to expand at the highest CAGR during the forecast period?
Which segment of the global bone grafts and substitutes market will generate the maximum revenue by 2028?
Which segment will expand at the highest CAGR during the forecast period?

Bone Grafts and Substitutes Market – Research Objectives and Research Approach
The comprehensive report on the global bone grafts and substitutes market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global bone grafts and substitutes market in terms of product, material, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2028 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global bone grafts and substitutes market.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Bone Grafts and Substitutes Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Bone Grafts and Substitutes Market Analysis and Forecast, 2017–2028
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Market Insights
5.1. Key Mergers & Acquisitions
5.2. Technological Advancements
6. Global Bone Grafts and Substitutes Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2028
6.3.1. Allografts
6.3.1.1. Demineralized Bone Matrix (DBM)
6.3.1.2. Others
6.3.2. Synthetic Bone Grafts
6.3.3. Xenografts
6.4. Market Attractiveness Analysis, by Product Type
7. Global Bone Grafts and Substitutes Market Analysis and Forecast, by Material
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Material, 2017–2028
7.3.1. Ceramic-based
7.3.1.1. Calcium Phosphate
7.3.1.2. Calcium Sulfate
7.3.1.3. Calcium Sulfate
7.3.2. Polymer-based
7.3.2.1. Polylactides
7.3.2.2. Polyglycolides
7.3.2.3. Polyurethanes
7.3.2.4. Others
7.3.3. Growth Factor-based
7.3.4. Cell Based
7.3.5. Others
7.4. Market Attractiveness Analysis, by Material
8. Global Bone Grafts and Substitutes Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2028
8.3.1. Hospitals
8.3.2. Orthopedic Clinics
8.3.3. Academic & Research Institutes
8.4. Market Attractiveness Analysis, by End-user
9. Global Bone Grafts and Substitutes Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Bone Grafts and Substitutes Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2028
10.2.1. Allograft
10.2.1.1. Demineralized Bone Matrix (DBM)
10.2.1.2. Others
10.2.2. Synthetic Bone Graft
10.2.3. Xenograft
10.3. Market Value Forecast, by Material, 2017–2028
10.3.1. Ceramic-based
10.3.1.1. Calcium Phosphate
10.3.1.2. Calcium Sulfate
10.3.1.3. Calcium Sulfate
10.3.2. Polymer-based
10.3.2.1. Polylactides
10.3.2.2. Polyglycolides
10.3.2.3. Polyurethanes
10.3.2.4. Others
10.3.3. Growth Factor-based
10.3.4. Cell-based
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2017–2028
10.4.1. Hospitals
10.4.2. Orthopedic Clinics
10.4.3. Academic & Research Institutes
10.5. Market Value Forecast, by Country, 2017–2028
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Material
10.6.3. By End-user
10.6.4. By Country
11. Europe Bone Grafts and Substitutes Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2028
11.2.1. Allograft
11.2.1.1. Demineralized Bone Matrix (DBM)
11.2.1.2. Others
11.2.2. Synthetic Bone Graft
11.2.3. Xenograft
11.3. Market Value Forecast, by Material, 2017–2028
11.3.1. Ceramic-based
11.3.1.1. Calcium Phosphate
11.3.1.2. Calcium Sulfate
11.3.1.3. Calcium Sulfate
11.3.2. Polymer-based
11.3.2.1. Polylactides
11.3.2.2. Polyglycolides
11.3.2.3. Polyurethanes
11.3.2.4. Others
11.3.3. Growth Factor-based
11.3.4. Cell-based
11.3.5. Others
11.4. Market Value Forecast, by End-user, 2017–2028
11.4.1. Hospitals
11.4.2. Orthopedic Clinics
11.4.3. Academic & Research Institutes
11.5. Market Value Forecast, by Country/Sub-region, 2017–2028
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Material
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Bone Grafts and Substitutes Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2028
12.2.1. Allograft
12.2.1.1. Demineralized Bone Matrix (DBM)
12.2.1.2. Others
12.2.2. Synthetic Bone Graft
12.2.3. Xenograft
12.3. Market Value Forecast, by Material, 2017–2028
12.3.1. Ceramic-based
12.3.1.1. Calcium Phosphate
12.3.1.2. Calcium Sulfate
12.3.1.3. Calcium Sulfate
12.3.2. Polymer-based
12.3.2.1. Polylactides
12.3.2.2. Polyglycolides
12.3.2.3. Polyurethanes
12.3.2.4. Others
12.3.3. Growth Factor-based
12.3.4. Cell-based
12.3.5. Others
12.4. Market Value Forecast, by End-user, 2017–2028
12.4.1. Hospitals
12.4.2. Orthopedic Clinics
12.4.3. Academic & Research Institutes
12.5. Market Value Forecast, by Country/Sub-region, 2017–2028
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Material
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Bone Grafts and Substitutes Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2028
13.2.1. Allograft
13.2.1.1. Demineralized Bone Matrix (DBM)
13.2.1.2. Others
13.2.2. Synthetic Bone Graft
13.2.3. Xenograft
13.3. Market Value Forecast, by Material, 2017–2028
13.3.1. Ceramic-based
13.3.1.1. Calcium Phosphate
13.3.1.2. Calcium Sulfate
13.3.1.3. Calcium Sulfate
13.3.2. Polymer-based
13.3.2.1. Polylactides
13.3.2.2. Polyglycolides
13.3.2.3. Polyurethanes
13.3.2.4. Others
13.3.3. Growth Factor-based
13.3.4. Cell-based
13.3.5. Others
13.4. Market Value Forecast, by End-user, 2017–2028
13.4.1. Hospitals
13.4.2. Orthopedic Clinics
13.4.3. Academic & Research Institutes
13.5. Market Value Forecast, by Country/Sub-region, 2017–2028
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Material
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Bone Grafts and Substitutes Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2028
14.2.1. Allograft
14.2.1.1. Demineralized Bone Matrix (DBM)
14.2.1.2. Others
14.2.2. Synthetic Bone Graft
14.2.3. Xenograft
14.3. Market Value Forecast, by Material, 2017–2028
14.3.1. Ceramic-based
14.3.1.1. Calcium Phosphate
14.3.1.2. Calcium Sulfate
14.3.1.3. Calcium Sulfate
14.3.2. Polymer-based
14.3.2.1. Polylactides
14.3.2.2. Polyglycolides
14.3.2.3. Polyurethanes
14.3.2.4. Others
14.3.3. Growth Factor-based
14.3.4. Cell-based
14.3.5. Others
14.4. Market Value Forecast, by End-user, 2017–2028
14.4.1. Hospitals
14.4.2. Orthopedic Clinics
14.4.3. Academic & Research Institutes
14.5. Market Value Forecast, by Country/Sub-region, 2017–2028
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Material
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2020
15.3. Company Profiles
15.3.1. AlloSource
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Financial Analysis
15.3.1.3. Growth Strategies
15.3.1.4. SWOT Analysis
15.3.2. DePuy Synthes
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Financial Analysis
15.3.2.3. Growth Strategies
15.3.2.4. SWOT Analysis
15.3.3. Integra LifeSciences
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Financial Analysis
15.3.3.3. Growth Strategies
15.3.3.4. SWOT Analysis
15.3.4. NuVasive, Inc.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Financial Analysis
15.3.4.3. Growth Strategies
15.3.4.4. SWOT Analysis
15.3.5. Stryker
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Financial Analysis
15.3.5.3. Growth Strategies
15.3.5.4. SWOT Analysis
15.3.6. Wright Medical Group N.V.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Financial Analysis
15.3.6.3. Growth Strategies
15.3.6.4. SWOT Analysis
15.3.7. Xtant Medical
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Financial Analysis
15.3.7.3. Growth Strategies
15.3.7.4. SWOT Analysis
15.3.8. Zimmer Biomet
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Financial Analysis
15.3.8.3. Growth Strategies
15.3.8.4. SWOT Analysis
15.3.9. Baxter Healthcare Corporation
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Financial Analysis
15.3.9.3. Growth Strategies
15.3.9.4. SWOT Analysis
15.3.10. Medtronic
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Financial Analysis
15.3.10.3. Growth Strategies
15.3.10.4. SWOT Analysis